GLYCAN BIOSCIENCES LLC

Glycan has developed a new class of anti-inflammation which have a broad potential in large indications (PoC in asthma) and orphan inflammatory diseases.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Philadelphia, PA, US
  • Currency USD
  • Founded January 2012
  • Employees 0
  • Incorporation Type LLC
  • Website glycanbio.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free